Dr. Alfayez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1400 Holcombe Blvd
Leukemia Department
Houston, TX 77030- Is this information wrong?
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2019
St Elizabeth's Medical CenterResidency, Internal Medicine, 2011 - 2014
OtherClass of 2008
Certifications & Licensure
MA State Medical License 2014 - 2021
Publications & Presentations
PubMed
- Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin.Riad El Fakih, Momen Nassani, Walid Rasheed, Amr Hanbali, Fahad Almohareb, Naeem Chaudhri, Fahad Alsharif, Feras Alfraih, Marwan Shaheen, Saud Alhayli, Hanan Alkhaldi,...> ;Transplantation and Cellular Therapy. 2024 Mar 1
- Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy.Jessica L Root, Poonam N Desai, Christopher Ly, Bofei Wang, Fatima Zahra Jelloul, Jing Zhou, Sean Mackay, Mansour Alfayez, Jairo Matthews, Sherry Pierce, Patrick K Rev...> ;Cancer Research Communications. 2024 Mar 6
- Cigarette smoke exposure accelerates AML progression in FLT3-ITD models.Mary Figueroa, Huaxian Ma, Mansour Alfayez, Daniel Enrique Morales-Mantilla, Fei Wang, Yue Lu, Marcos R Estecio, Katherine Y King, Eugenie Kleinerman, Seyed Javad Mogh...> ;Blood Advances. 2023 Nov 14
- Join now to see all
Abstracts/Posters
- Azacitidine (AZA) with Nivolumab (Nivo), and AZA with Nivo + Ipilimumab (Ipi) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Prospective, Phase 2 StudyMansour Alfayez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Activity of Multiple Targetable Therapies in FLT3-Mutated (mu) Acute Myeloid Leukemia (AML) Patients (pts) with Concurrent Isocitrate Dehydrogenase Mutation (IDHm)Mansour Alfayez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Acceleration of AML Progression By Cigarette Smoke Exposure or Condensate Exposure and Associated DNA Methylation AlterationsMansour Alfayez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Association of smoking with poor risk ELN 2017, cytogenetics/molecular profile, and survival outcomes in acute myeloid leukemia.2019 ASCO Annual Meeting - 6/1/2019
- Impact of variant allele frequency of mutant PTPN11 in AML: Single institution experience of 122 patients.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Characteristics and outcomes of myelodysplastic syndrome (MDS) with chromosome (chr)3q abnormalities.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Other Languages
- Arabic
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
